prism, 0.65 6 0.41 6 0.40 mm; orthorhombic, Cmc21 (no. 36); a =
3
˚
˚
11.9746(7), b = 18.4624(11), c = 10.3004(6) A, V = 2277.2(2) A ; Dc
=
˚
1.337 Mg m23; m = 0.094 mm21; Mo-Ka radiation, l = 0.71073 A;
T = 193 K; 2hmax = 52.76u; 8287 reflections measured (2437 independent);
structure solution and refinement using SHELXS-97 and SHELXL-97
(G. M. Sheldrick, University of Go¨ttingen, Go¨ttingen (Germany), 1997);
183 parameters, hydrogen atoms generated in idealized positions; R1
=
0.0262 (for 2386 reflns with I . 2s(I)), wR2 = 0.0709 (for all 2437
independent reflections). CCDC 637204. For crystallographic data in CIF
or other electronic format see DOI: 10.1039/b705256a.
§ As expected, the host’s other protons all move downfield upon binding
any cationic guest and the guests’ methyl protons move upfield upon
binding the anionic host.
1 R. J. Herr, Bioorg. Med. Chem., 2002, 10, 3379.
2 A. F. Tominey, P. H. Docherty, G. M. Rosair, R. Quenardelle and
A. Kraft, Org. Lett., 2006, 8, 1279.
3 L. Peters, R. Froehlich, A. S. F. Boyd and A. Kraft, J. Org. Chem.,
2001, 66, 3291.
4 A. Kraft, F. Osterod and R. Froehlich, J. Org. Chem., 1999, 64, 6425.
5 A. Taden, A. H. Tait and A. Kraft, J. Polym. Sci., Part A: Polym.
Chem., 2002, 40, 4333.
6 A. Tominey, D. Andrew, L. Oliphant, G. M. Rosair, J. Dupre and
A. Kraft, Chem. Commun., 2006, 2492.
Fig. 4 A portion of Type II dehydroquinase-inhibitor complex (PDB
code 2C4W18) showing edge-on hydrogen bonds (dashed lines) and face-
on hydrophobic contacts (solid lines) between the tetrazolate of the
˚
inhibitor and neighboring fragments. Selected distances (A) between heavy
7 T. D. P. Stack, Z. Hou and K. N. Raymond, J. Am. Chem. Soc., 1993,
115, 6466–6467.
8 G. Hennrich and E. V. Anslyn, Chem.–Eur. J., 2002, 8, 2219–2225.
9 A. Metzger, V. M. Lynch and E. V. Anslyn, Angew. Chem., Int. Ed.
Engl., 1997, 36, 862.
atoms are indicated.
authors could only attribute to a structurally undefined ‘‘non-
conventional salt bridge’’ between losartan’s tetrazolate and the
AT1 receptor’s Lys199.14 More than ten years later, the nature of
the interaction between the tetrazolate of losartan (and those of
newer tetrazolate-containing AT1 antagonists) and the protein is
still debated,15,16 but our current results are most consistent with a
recently published model15 in which the c, d, e methylenes of
Lys199 make a hydrophobic contact with losartan’s tetrazolate
face.17 Further evidence for the relevance of geometry-dependent
hydrophobicity for tetrazolates comes from one of the few crystal
structures of a bound anionic tetrazolate ligand in the Protein
Data Bank. The structure of a tetrazolate ligand bound to Type II
DHQase from H. pylori (PDB code 2C4W)18 reveals a significant
hydrophobic contact on each face of the inhibitor’s tetrazolate ring
and an equator of hydrogen bonding contacts to polar residues
positioned around the tetrazolate’s edges (Fig. 4).
10 Z. P. Demko and K. B. Sharpless, J. Org. Chem., 2001, 66, 7945.
11 ‘Spartan ‘04’, Wavefunction, Irvine, USA, 2004.
12 R. R. Wexler, W. J. Greenlee, J. D. Irvin, M. R. Goldberg,
K. Prendergast, R. D. Smith and P. B. M. W. M. Timmermans,
J. Med. Chem., 1996, 39, 625.
13 D. J. Carini, J. V. Duncia, P. E. Aldrich, A. T. Chiu, A. L. Johnson,
M. E. Pierce, W. A. Price, J. B. Santella, G. J. Wells, R. R. Wexler,
P. C. Wong, S.-E. Yoo and P. B. M. W. M. Timmermans, J. Med.
Chem., 1991, 34, 2525.
14 K. Noda, Y. Saad, A. Kinoshita, T. P. Boyle, R. M. Graham, A. Husain
and S. S. Karnik, J. Biol. Chem., 1995, 270, 2284.
15 A. Patny, P. V. Desai and M. A. Avery, Proteins: Struct., Funct., Bioinf.,
2006, 65, 824.
16 T. Tuccinardi, V. Calderone, S. Rapposelli and A. Martinelli, J. Med.
Chem., 2006, 49, 4305.
17 The structurally analogous interaction of Lysine’s e-CH2 group with
neutral aromatic side chains such as Trp is also energetically favorable.
See: C. D. Tatko and M. L. Waters, Protein Sci., 2003, 12, 2443–2452;
M. J. Rashkin, R. M. Hughes, N. T. Calloway and M. L. Waters, J. Am.
Chem. Soc., 2004, 126, 13320–13325; C. D. Tatko and M. L. Waters,
J. Am. Chem. Soc., 2004, 126, 2028–2034; R. M. Hughes and
M. L. Waters, J. Am. Chem. Soc., 2005, 127, 6518–6519.
18 D. A. Robinson, K. A. Stewart, N. C. Price, P. A. Chalk, J. R. Coggins
and A. J. Lapthorn, J. Med. Chem., 2006, 49, 1282.
19 J. Chin, C. Walsdorff, B. Stranix, J. Oh, H. J. Chung, S.-M. Park and
K. Kim, Angew. Chem., Int. Ed., 1999, 38, 2756.
20 J. Chin, J. Oh, S. Y. Jon, S. H. Park, C. Walsdorff, B. Stranix,
A. Ghoussoub, S. J. Lee, H. J. Chung, S.-M. Park and K. Kim, J. Am.
Chem. Soc., 2002, 124, 5374.
21 S.-G. Kim and K. H. Ahn, Chem.–Eur. J., 2000, 6, 3399.
22 K. H. Ahn, S.-G. Kim, J. Jung, K.-H. Kim, J. Kim, J. Chin and K. Kim,
Chem. Lett., 2000, 170.
In terms of binding capabilities in physiologically relevant
solutions, our tetrazole-derived host occupies a middle ground
between related hosts built using neutral heterocycles19–26 (which
rely on uncharged hydrogen bonds too weak to bind cationic
guests in pure water without extensive hydrophobic decoration27)
and carboxylate host 2-Na3 (which can employ electrostatic
attraction for binding in less polar solvents, but is too well solvated
to bind ammonium ion guests in pure water). We are currently
seeking hosts with higher affinity for quaternary ammonium ions
in order to take advantage of the attractive features of tetrazole-
derived hosts (low molecular weight, ease of synthesis, and good
pharmacological properties) not found in classical cyclophane-
derived quaternary ammonium ion receptors.28–30
23 S.-G. Kim, K.-H. Kim, J. Jung, S. K. Shin and K. H. Ahn, J. Am.
Chem. Soc., 2002, 124, 591.
24 S.-G. Kim, K.-H. Kim, Y. K. Kim, S. K. Shin and K. H. Ahn, J. Am.
Chem. Soc., 2003, 125, 13819.
The authors thank Tom Fyles for expert assistance with pKa
determinations. This research was funded by NSERC, CFI/
BCKDF, and the University of Victoria.
25 K. H. Ahn, H.-y. Ku, Y. Kim, S.-G. Kim, Y. K. Kim, H. S. Son and
J. K. Ku, Org. Lett., 2003, 5, 1419.
26 J. Kim, S.-G. Kim, H. R. Seong and K. H. Ahn, J. Org. Chem., 2005,
70, 7227.
27 J. Kim, B. Raman and K. H. Ahn, J. Org. Chem., 2006, 71, 38.
28 J. C. Ma and D. A. Dougherty, Chem. Rev., 1997, 97, 1303.
29 E. A. Meyer, R. K. Castellano and F. Diederich, Angew. Chem., Int.
Ed., 2003, 42, 1210.
Notes and references
{ Crystals of 1?H2O?MeOH grown by slow evaporation of a wet
methanol solution of 1: C19H30N12O2, Mr = 458.55 g mol21; colorless
30 P. Lhota´k and S. Shinkai, J. Phys. Org. Chem., 1997, 10, 273.
3740 | Chem. Commun., 2007, 3738–3740
This journal is ß The Royal Society of Chemistry 2007